Botanical species · safety record

Ginkgo biloba

The EFSA Compendium of Botanicals holds 3 constituent measurements, 6 adverse-effect records and 5 genotoxicity assays for Ginkgo biloba. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Ginkgo biloba L.

3Constituent measurements
11Safety records
7Cited sources
2,604Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 2,604 licensed products naming Ginkgo biloba as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA
  • Fresh
  • fluid
  • solid

Source material stated

  • Bud
  • Buds
  • Dried leaf
  • Dried leaves
  • Fresh leaf
  • Fresh leaves
  • Fresh leaves during spring
  • Ginkgo biloba

What the records describe

Constituents measured

  • Diterpenes1
  • Ginkgotoxin1
  • Proanthocyanidins (condensed tannins)1

Plant parts

  • Leaves3
  • Seed3
  • Aerial part of plants2
  • Unspecified1

Preparations

  • Solvent extraction4

Effect types

  • Hepatotoxicity4
  • Neurotoxicity2

Target tissues

  • Liver4
  • Digestive1
  • Neurologic1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
DiterpenesAerial part of plantsUnspecifiedResolve DOI
GinkgotoxinSeedSolvent extraction0.01 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
Proanthocyanidins (condensed tannins)Aerial part of plantsUnspecifiedResolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
HepatotoxicityLiverUnspecifiedHouse mouse (as animal)Chronic/long term toxicityResolve DOI
HepatotoxicityLiverLeavesSolvent extractionHouse mouse (as animal)Short-term toxicityResolve DOI
HepatotoxicityLiverLeavesSolvent extractionHouse mouse (as animal)Short-term toxicityResolve DOI
HepatotoxicityLiverLeavesSolvent extractionHouse mouse (as animal)SubchronicResolve DOI
NeurotoxicityNeurologicSeedHuman (as organism)Case reportResolve DOI
NeurotoxicityDigestiveSeedHuman (as organism)Case reportResolve DOI

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

OutcomeEndpointTestTested organismMetabolic activationSource
PositiveDNA damage and/or repairsingle cell gel/comet assay in mammalian cells for detection of DNA damageHouse mouse (as animal)Resolve DOI
PositiveDNA damage and/or repairsingle cell gel/comet assay in mammalian cells for detection of DNA damageHuman (as organism)WithResolve DOI
PositiveDNA damage and/or repairsingle cell gel/comet assay in mammalian cells for detection of DNA damageOtherResolve DOI
Positivegene mutationbacterial reverse mutation assaySalmonella typhimurium (as organism)Resolve DOI
Positivegene mutationmammalian cell gene mutation assayHouse mouse (as animal)With and withoutResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Di Lorenzo, Chiara., Ceschi, Alessandro., Colombo, Francesca., Frigerio, Gianfranco., Bianchetti, Mario G., Luede, Saskia., von Dechend, Margot., Valoti, Ermanno., Restani, Patrizia. Identification and quantification of biomarkers to confirm the poisoning by Ginkgo biloba seeds in a 2-year-old boy. Toxicology research, 2015, vol. 4, no. 4, p. 922-930. DOI
  2. Zhang, Z., Mei, N., Chen, S., Guo, L., Guo, X. Assessment of Genotoxic Effects of Selected Herbal Dietary Supplements. Nutraceuticals: efficacy, safety and toxicity, 2016, p. 883-892. DOI
  3. Maeda, Jun., Kijima, Aki., Inoue, Kaoru., Ishii, Yuji., Ichimura, Ryohei., Takasu, Shinji., Kuroda, Ken., Matsushita, Kohei., Kodama, Yukio., Saito, Naoaki., Umemura, Takashi., Yoshida, Midori. In Vivo Genotoxicity of Ginkgo Biloba Extract in gpt Delta Mice and Constitutive Androstane Receptor Knockout Mice. Toxicological sciences, 2014, vol. 140, no. 2, p. 298-306. DOI
  4. Sado, Tomomitsu., Nakata, Setsuko., Tsuno, Takahisa., Sato, Masanori., Misawa, Yuka., Yamauchi, Shoko., Inaba, Yuji., Kobayashi, Daisuke., Wada, Keiji. Concentrations of various forms of vitamin B-6 in ginkgo seed poisoning. Brain & development, 2019, vol. 41, no. 3, p. 292-295. DOI
  5. Zhang, Zhuhong., Chen, Si., Mei, Hu., Xuan, Jiekun., Guo, Xiaoqing., Couch, Letha., Dobrovolsky, Vasily N., Guo, Lei., Mei, Nan. Ginkgo biloba leaf extract induces DNA damage by inhibiting topoisomerase II activity in human hepatic cells. Scientific reports, 2015, vol. 5. DOI
  6. Lin, Haixia., Guo, Xiaoqing., Zhang, Suhui., Dial, Stacey L., Guo, Lei., Manjanatha, Mugimane G., Moore, Martha M., Mei, Nan. Mechanistic Evaluation of Ginkgo biloba Leaf Extract-Induced Genotoxicity in L5178Y Cells. Toxicological sciences, 2014, vol. 139, no. 2, p. 338-349. DOI
  7. Wada, K., Ishigaki, S., Ueda, K., Take, Y., Sasaki, K., Sakata, M., Haga, M. Studies on the Constitution of Edible and Medicinal Plants. I. Isolation and Identification of 4-0-Methylpyridoxine, Toxic Principle from the Seed of Ginkgo biloba L.. Chemical and pharmaceutical bulletin, 1988, vol. 36, no. 5, p. 1779-1782. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue